EPO levels were higher in patients than in the control group, where a statistically significant difference was found in the OSA vs. the control group (16.80 vs. 5.98, p < 0.001 after Bonferroni correction). The gene discussed is EPO; the disease is obstructive sleep apnea syndrome.